RecruitingMalignant Solid Neoplasm

Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)

Eligible age

All ages

Accepts

All genders

Locations

32 states

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This clinical trial evaluates the effect of Cost Communication and Financial Navigation (CostCOM) intervention on adherence to care and financial burden in cancer patients. Many cancer patients experience financial hardship due to high medical out of pocket costs (OOPC), changes in employment, income and insurance. Financial hardship can lead to a delay or a stop in cancer care, and is linked to poor quality of life. Financial navigation programs, such as CostCOM, provide financial counseling, education and connections to appropriate resources to reduce financial barriers to healthcare and minimize financial stress and burden. CostCOM may improve adherence to care and decrease financial burden in patients with cancer.

Sponsor: ECOG-ACRIN Cancer Research Group

You may qualify if…

✓ NON-PATIENTS PARTICIPANTS: Participant must speak English
✓ NON-PATIENTS PARTICIPANTS: Participant must be employed at National Cancer Institute Community Oncology Research Program (NCORP) site for at least six months
✓ NON-PATIENTS PARTICIPANTS: Participant must be able to provide informed consent to participate in this study
✓ NON-PATIENTS PARTICIPANTS: Participant must be one of the following:
✓ A study coordinator with a role involving use of CostCOM intervention price transparency and financial navigation platform
✓ A practice oncology provider (i.e., physician or mid-level), or
✓ A practice financial counselor, social workers, financial navigators, or pharmacist who have provided care or been in contact (in the last 3 months) to a patient who was assigned to the CostCOM arm, and who completed the at least 6 month study follow-up
✓ PATIENT ELIGIBILITY CRITERIA FOR STEP 0 (OPEN SCREENING REGISTRATION): Patient must be ≥ 18 years of age